Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

In addition to Bourla, other famous Jews with roots in Thessaloniki include actor Hank Azaria, Israeli businessman and ...

Managed care stocks came under pressure after Pfizer CEO Albert Bourla said U.S. President-elect Donald Trump is “very committed” to reforming the pharmacy benefit manager industry, with Humana (HUM) ...

( MENAFN - Baystreet) Shares in health Insurers fell again. On Tuesday, Pfizer's (PFE) CEO, Albert Bourla, revealed that ...

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with ...

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...

Pfizer said it had achieved $4 billion in net cost savings through 2024 and that it expects full-year 2025 revenue to range ...

Pharmaceuticals giant Pfizer closed Tuesday's session nearly 5% in the green, after it issued an upbeat full-year outlook for ...

Pfizer is fending off investors’ fears about threats to its vaccine business under the Trump administration.

Sometimes, markets don’t need breathless buzzwords to get excited. Sometimes, “marginally encouraging” will do. Ask Pfizer ...

The Dow Jones Industrial Average was losing 370 points, or 0.8%, to trade near its session low of 43,336 as of 3:20 p.m.

Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump ...